Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze BMRN stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BMRN investment potential.

What is BMRN stock price today?

Get real-time BMRN stock price, historical data, and price charts on Financhill. Track BMRN performance with our advanced analysis tools.

Is BMRN a good investment?

Evaluate BMRN investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BMRN stock?

To buy BMRN stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BMRN?

View detailed market capitalization data and company valuation metrics for BMRN on our comprehensive analysis page.

What is the P/E ratio of BMRN?

Use our fundamental analysis tools to view BMRN P/E ratio and compare valuation metrics with industry peers.

What are BMRN earnings?

View BMRN earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

BioMarin Pharmaceutical, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:

$53.10

Seasonality Move:

10.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Still Time to Get In: RAD Intel at $0.85/Share

BioMarin Pharmaceutical, Inc. Stock Forecast

Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 10.4% based on the past 26 years of stock performance.
BioMarin Pharmaceutical, Inc. has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%
Is BioMarin Pharmaceutical, Inc. Stock Undervalued?

The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $53.40. The Score for BMRN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BioMarin Pharmaceutical, Inc. Stock Go Up Next Year?

Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 10.4% based on the past 26 years of stock performance.

BioMarin Pharmaceutical, Inc. Stock Rating

Sell

BioMarin Pharmaceutical, Inc. (BMRN) is a Sell

Is BioMarin Pharmaceutical, Inc. overpriced?

BioMarin Pharmaceutical, Inc. has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%

BioMarin Pharmaceutical, Inc. Stock Price History

Is BMRN stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

biomarin.com

52-Week Data

52-Week High:

73.51

52-Week Low:

50.76

Prediction Charts

Market Cap:

10.3B

Price in USD:

53.40

Volume:

2.2M

Beta:

0.84

Technical Analysis

SMA50:

53.83

SMA100:

55.53

SMA200:

58.74

52-Wk Change:

-19.29%

Stock Predictions

Is BioMarin Pharmaceutical, Inc. stock public?

Yes, BioMarin Pharmaceutical, Inc. is a publicly traded company.
What is the BioMarin Pharmaceutical, Inc. stock quote today?

The BioMarin Pharmaceutical, Inc. stock price is 53.40 USD today.
How to buy BioMarin Pharmaceutical, Inc. stock online?

You can buy BioMarin Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	54.13	54.46	55.24	54.00
Nov-18	54.32	54.16	54.52	52.91
Nov-19	53.88	52.56	53.88	51.99
Nov-20	52.62	52.48	53.73	52.36
Nov-21	52.72	54.69	54.76	52.51
Nov-24	54.22	55.50	56.13	53.93
Nov-25	55.60	56.29	56.45	55.35
Nov-26	56.26	55.52	56.39	54.51
Nov-28	55.77	55.93	56.05	55.03
Dec-1	55.50	55.03	56.09	54.95
Dec-2	55.22	53.89	55.34	53.88
Dec-3	53.52	54.31	54.40	53.03
Dec-4	54.33	53.82	54.66	53.64
Dec-5	53.55	53.40	53.83	52.88

BioMarin Pharmaceutical, Inc. Earnings

BioMarin Pharmaceutical, Inc. Earnings Report: Per Share BioMarin Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

BioMarin Pharmaceutical, Inc. Forecast Revenue Growth

BioMarin Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for BioMarin Pharmaceutical, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.